Detalles de la búsqueda
1.
The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide.
Mult Scler J Exp Transl Clin;
7(4): 20552173211066588, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34950502
2.
A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers.
Mult Scler Relat Disord;
51: 102861, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33773271
Resultados
1 -
2
de 2
1
Próxima >
>>